Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report

RATIONALE: Blastic plasmacytoid dendritic cell neoplasm (BPDCN), derived from precursors of plasmacytoid dendritic cells, is a rare and aggressive malignancy with frequent cutaneous involvement. Although cutaneous lesions are often chemosensitive, BPDCN portends a poor prognosis as most patients rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Grushchak, Solomiya, Joy, Cossette, Gray, Arielle, Opel, Dan, Speiser, Jodi, Reserva, Jeave, Tung, Rebecca, Smith, Scott E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758283/
https://www.ncbi.nlm.nih.gov/pubmed/29390581
http://dx.doi.org/10.1097/MD.0000000000009452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758283/
https://www.ncbi.nlm.nih.gov/pubmed/29390581
http://dx.doi.org/10.1097/MD.0000000000009452

Ejemplares similares